By disrupting cholesterol homeostasis and lipid rafts and altering amyloid and tau processing, Nef may contribute to HAND pathogenesis through mechanisms similar to those observed in Alzheimer’s disease, thereby extending its possible clinical relevance beyond HAND. This evidence concerns the gene S100B and early-onset autosomal dominant Alzheimer disease.